Skip to main content
Log in

Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients

  • Brief Report
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

Abstract

Objective

To describe clinical, neuroradiological and evolutionary findings in obstetric patients with posterior reversible encephalopathy syndrome (PRES).

Design

Retrospective case series.

Setting

University intensive care unit (ICU).

Patients

Four critically ill patients. Two patients experienced PRES in late postpartum without the classical pre-eclamptic signs. All patients showed impairment of consciousness and epileptic seizures; two of them presented cortical blindness and headache, too. True status epilepticus (SE) occurred in two cases. In all patients MRI showed the typical feature of gray-white matter edema, mainly localized to the temporo-parieto-occipital areas.

Interventions

Normalization of high blood pressure (BP) and treatment of seizures. Two patients with SE and severe impairment of consciousness were treated with an intravenous valproate (ivVPA) bolus followed by continuous infusion.

Measurements and results

In three cases, neurological and MRI abnormalities completely resolved in about a week. Another patient died due to subarachnoid hemorrhage.

Conclusion

Posterior reversible encephalopathy syndrome is a well described clinical and neuroradiological syndrome characterized by headache, altered mental status, cortical blindness and seizures, and a diagnostic MRI picture; usually reversible, PRES can sometimes result in death or in irreversible neurological deficits, thus requiring early diagnosis and prompt treatment. PRES can have various etiologies, but pregnancy and postpartum more frequently lead to this condition. Treatment of seizures deserves special attention since the anti-epileptic drugs currently used in SE management may worsen vigilance as well as autonomic functions. Extensive research is needed to assess the role of ivVPA in this condition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

References

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin M, Lamy C, Mas JLM, Caplan LR (1996) A reversible posterior encephalopathy syndrome. N Engl J Med 334:494–500

    Article  CAS  Google Scholar 

  2. Kwon S, Jahoon K, Sangkwon L (2001) Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 24:361–364

    Article  CAS  Google Scholar 

  3. Covarrubias DJ, Luetmer PH, Campeau NG (2002) Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. Am J Neuroradiol 23:1038–1048

    PubMed  Google Scholar 

  4. Antunes NL, Small TN, George D, Boulad F, Lis E (1999) Posterior leukoencephalopathy syndrome may not be reversible. Pediatr Neurol 20:241–243

    Article  CAS  Google Scholar 

  5. Kupferschmidt H, Bont A, Schnorf H, Landis T, Walter E, Peter J, Krahenbuhl S, Meier PJ (1995) Transient cortical blindness and bioccipital brain lesions in two patients with acute intermittent porphyria. Ann Intern Med 123:598–600

    Article  CAS  Google Scholar 

  6. Kastrup O, Maschke M, Wanke I, Diener HC (2002) Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249:1563–1566

    Article  CAS  Google Scholar 

  7. Pavlakis SG, Frank Y, Kalina P, Chandra M, Lu D (1997) Occipital-parietal encephalopathy: a new name for an old syndrome. Pediatr Neurol 16:145–148

    Article  CAS  Google Scholar 

  8. Casey SO, Sampaio RC, Michel E, Truwit CL (2000) Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcortical lesions. Am J Neuroradiol 21:1199–1206

    CAS  PubMed  Google Scholar 

  9. Schaefer PW, Buonanno FS, Gonzales RG, Schwamm LH (1997) Diffusion-weighted imaging discriminates between cytotoxic and vasogenic edema in a patient with eclampsia. Stroke 28:1082–1085

    Article  CAS  Google Scholar 

  10. Keswani SC, Wityk R (2002) Don't throw in the towel! A case of reversible coma. J Neurol Neurosurg Psychiatry 73:83–84

    Article  CAS  Google Scholar 

  11. Veltkamp R, Kupsch A, Polasek J, Yousry TA, Pfister HW (2000) Late onset postpartum eclampsia without pre-eclamptic prodomi: clinical and neuroradiological presentation in two patients. J Neurol Neurosurg Psychiatry 69:824–827

    Article  CAS  Google Scholar 

  12. Dziewas R, Stogbauer F, Freund M, Ludemann P, Imai T, Holzapfel C, Ringelstein PB (2002) Late onset postpartum eclampsia: a rare and difficult diagnosis. J Neurol 9:1287–1291

    Article  Google Scholar 

  13. Manfredi M, Beltramello A, Bongiovanni LG, Polo A, Pistoia L, Rizzuto N (1997) Eclamptic encephalopathy: imaging and pathogenetic considerations. Acta Neurol Scand 96:277–282

    Article  CAS  Google Scholar 

  14. Schwartz RB, Feske SK, Polak JF, DeGirolami U, Iaia A, Beckner KM, Bravo SM, Klufas RA, Chai RY, Repke JT (2000). Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insight into the pathogenesis of hypertensive encephalopathy. Radiology 217:371–376

    Article  CAS  Google Scholar 

  15. Thambisetty M, Biousse V, Newman NJ (2003) Hypertensive brainstem encephalopathy: clinical and radiographic features. J Neurol Sci 208:93–99

    Article  Google Scholar 

  16. Sengar AR, Gupta RK, Dhanuka AR, Roy R, Das K (1997) MR imaging, MR angiography and MR spectroscopy of the brain in eclampsia. Am J Neuroradiol 18:1485–1490

    CAS  PubMed  Google Scholar 

  17. Kaplan PW (2002) Neurologic aspects of eclampsia. In: Hainline B, Devinsky O (eds) Neurological complication of pregnancy (2nd edition). Lippincott Williams & Wilkins, Baltimore, pp 41–49

  18. Luiten PG, Douma BR, Van der Zee EA, Nyakas C (1995) Neuroprotection against NMDA induced cell death in rat nucleus basalis by Ca2+ antagonist nimodipine, influence of aging and developmental drug treatment. Neurodegeneration 4:307–314

    Article  CAS  Google Scholar 

  19. Harkany T. Dijkstra IM, Oosterink BJ, Horvath KM, Abraham I, Keijser J, Van der Zee EA, Luiten PG (2000) Amyloid precursor protein expression and serotonergic sprouting following excitotoxic lesion of the rat magnocellular nucleus basalis: neuroprotection by Ca(2+) antagonist nimodipine. Neuroscience 101:101–114

    Article  CAS  Google Scholar 

  20. The Magpie Trial Collaborative Group (2002) Do women with pre-eclampsia, and their babes, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359:1877–1890

    Article  Google Scholar 

  21. Ramsay RE, Uthman B, Leppik IE, Pellock JM, Wilder BJ, Morris D, Cloyd JC (1997) The tolerability and safety of valproate sodium injection given as an intravenous infusion. J Epilepsy 10:187–193

    Article  Google Scholar 

  22. Sihna S, Naritoku DK (2000) Intravenous valproate is well tolerated in unstable patients with status epilepticus. Neurology 55:722–724

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuseppe Servillo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Servillo, G., Striano, P., Striano, S. et al. Posterior reversible encephalopathy syndrome (PRES) in critically ill obstetric patients. Intensive Care Med 29, 2323–2326 (2003). https://doi.org/10.1007/s00134-003-1901-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-003-1901-1

Keywords

Navigation